<p>M&As that led to the current 12 largest Big Pharma firms. (source: SDC Platinum Database (ThomsonReuters))</p
Context: Dramatic increases in pharmaceutical merger and acquisition (M&A) activity since 2010 sugge...
<div><p>In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters’ ...
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent e...
<p>Showing access to knowledge/assets in alliances with ‘Pharma’ companies and ‘Biotech’ companies a...
The aims of this paper are to study the e¤ects of mergers on the R&D activity of consolidated \u...
Despite continuing financial success, many big pharmaceutical companies are facing an uncertain futu...
The pharmaceutical industry is characterized by many industry-specific conditions that differentiate...
We examine the determinants and drivers of 112 mergers and acquisitions (M&A) activities exceed 50 m...
We examine the determinants and effects of M&A activity in the pharmaceutical/ biotechnology industry...
Recent years have seen exciting breakthroughs in biomedical sciences that are producing truly novel ...
In this chapter, the authors analyze strategic global development trends and competitiveness in the ...
The retail pharmacy industry is the primary source of prescription medication for Americans. It has ...
This paper takes a new look at the e¤ects of mergers on innova-tion by analysing the relationship be...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characteris...
Context: Dramatic increases in pharmaceutical merger and acquisition (M&A) activity since 2010 sugge...
<div><p>In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters’ ...
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent e...
<p>Showing access to knowledge/assets in alliances with ‘Pharma’ companies and ‘Biotech’ companies a...
The aims of this paper are to study the e¤ects of mergers on the R&D activity of consolidated \u...
Despite continuing financial success, many big pharmaceutical companies are facing an uncertain futu...
The pharmaceutical industry is characterized by many industry-specific conditions that differentiate...
We examine the determinants and drivers of 112 mergers and acquisitions (M&A) activities exceed 50 m...
We examine the determinants and effects of M&A activity in the pharmaceutical/ biotechnology industry...
Recent years have seen exciting breakthroughs in biomedical sciences that are producing truly novel ...
In this chapter, the authors analyze strategic global development trends and competitiveness in the ...
The retail pharmacy industry is the primary source of prescription medication for Americans. It has ...
This paper takes a new look at the e¤ects of mergers on innova-tion by analysing the relationship be...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis charact...
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characteris...
Context: Dramatic increases in pharmaceutical merger and acquisition (M&A) activity since 2010 sugge...
<div><p>In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters’ ...
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent e...
DOI
Add to ORKG